Saturday, June 9, 2012
Johnson & Johnson diabetes drug tops older therapies in studies - Reuters
Johnson & Johnson diabetes drug tops older therapies in studiesReutersBy Bill Berkrot (Reuters) - An experimental treatment for type 2 diabetes developed by Johnson & Johnson demonstrated greater reduction in blood sugar than Merck & Co's Januvia and an older common treatment, glimepiride, according to data from a pair ...Clinical Studies Show New, Proposed J&J Diabetes Drug Cuts Blood SugarFox BusinessCanagliflozin Provided Substantial and Sustained Glycemic Improvements as
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment